TR200301916T4 - Rotigotinin yüksek plazma seviyelerini kapsayan parkinson hastalığına yönelik transdermal terapötik sistem. - Google Patents

Rotigotinin yüksek plazma seviyelerini kapsayan parkinson hastalığına yönelik transdermal terapötik sistem.

Info

Publication number
TR200301916T4
TR200301916T4 TR2003/01916T TR200301916T TR200301916T4 TR 200301916 T4 TR200301916 T4 TR 200301916T4 TR 2003/01916 T TR2003/01916 T TR 2003/01916T TR 200301916 T TR200301916 T TR 200301916T TR 200301916 T4 TR200301916 T4 TR 200301916T4
Authority
TR
Turkey
Prior art keywords
rotigotine
parkinson
therapeutic system
transdermal therapeutic
plasma levels
Prior art date
Application number
TR2003/01916T
Other languages
English (en)
Inventor
Thomas Lauterbach Dr.
Wilhelm Schacht Dietrich
Hans-Michael Wolff Dr.
Walter Müller Dr.
Original Assignee
Schwarz Pharma Ag
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma Ag, Lts Lohmann Therapie-Systeme Ag filed Critical Schwarz Pharma Ag
Priority claimed from EP01111110A external-priority patent/EP1256340B1/en
Priority claimed from EP01111109A external-priority patent/EP1256339B1/en
Publication of TR200301916T4 publication Critical patent/TR200301916T4/tr

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Bu bulus, uygulandiktan 24 saat sonra rotigotinin ortalama plazma kosantrasyonunu 0.4 ila 2 ng/ml araligina getiren bir anti-Parkinson ilaci hazirlamak için 10 ila 40 cm arasinda bir alana sahip olan ve aktif bilesen olarak serbest baz formunda cm basina 0.1 ila 3.15 mg rotigotin ihtiva eden silikon bazli transdermal terapötik bir sistemin kullanilmasini saglar.
TR2003/01916T 2001-05-08 2001-05-08 Rotigotinin yüksek plazma seviyelerini kapsayan parkinson hastalığına yönelik transdermal terapötik sistem. TR200301916T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01111110A EP1256340B1 (en) 2001-05-08 2001-05-08 Improved transdermal therapeutic system for the treatment of Parkinson's disease
EP01111109A EP1256339B1 (en) 2001-05-08 2001-05-08 Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine

Publications (1)

Publication Number Publication Date
TR200301916T4 true TR200301916T4 (tr) 2004-01-21

Family

ID=33160923

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01916T TR200301916T4 (tr) 2001-05-08 2001-05-08 Rotigotinin yüksek plazma seviyelerini kapsayan parkinson hastalığına yönelik transdermal terapötik sistem.

Country Status (1)

Country Link
TR (1) TR200301916T4 (tr)

Similar Documents

Publication Publication Date Title
CY1109861T1 (el) Διαδερμικο θεραπευτικο συστημα για την ασθενεια του παρκινσον που προκαλει υψηλα επιπεδα πλασματος της ροτιγοτινης
CY1111880T1 (el) Βελτιωμενο διαδερμικο θεραπευτικο συστημα για την αγωγη της νοσου του parkinson
TW200505402A (en) Ophthalmic drug delivery device
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
AP1760A (en) Platinum derivative pharmaceutical formulations.
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
BRPI0608297A2 (pt) composições de lipossomos
ATE389385T1 (de) Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
AR032293A1 (es) Estuche farmaceutico
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
WO2007046103A3 (en) System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof
ATE541562T1 (de) Ibuprofen-suspension
SE0102440D0 (sv) New compound
TR200301916T4 (tr) Rotigotinin yüksek plazma seviyelerini kapsayan parkinson hastalığına yönelik transdermal terapötik sistem.
TR200601092T1 (tr) İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar.
MXPA05012826A (es) Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen.
SE0203817D0 (sv) New composition
ECSP961863A (es) Compuesto activo farmacologicamente
MD20050040A (ro) Metodă de normalizare a activităţii funcţionale a limfocitelor
UA3848U (uk) Спосіб активації процесів метаболізму у високопродуктивних корів
RU2007120495A (ru) Анорексигенное и регулирующее массу тела лекарственное средство